Summary & Overview
HCPCS Level II Q4272: Esano a per Square Centimeter (Add-on)
HCPCS Level II code Q4272 specifies an add-on billing descriptor for “Esano a, per square centimeter,” used to report a supplementary procedural product or localized treatment billed in addition to a primary procedure. As an add-on code, Q4272 does not stand alone and must be submitted alongside the primary service that it augments. Nationwide relevance stems from its role in correct claim composition and clarity in billing for area-based products or treatments where surface area is the unit of measure.
Key payers analyzed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the code’s clinical and billing context, common payer considerations, and the types of sites where the add-on is typically billed. The publication outlines benchmarks for coding practice, notes policy and coverage themes that affect add-on reporting, and summarizes clinical scenarios in which a per-square-centimeter add-on is applicable.
This resource is intended for billing managers, revenue cycle analysts, and clinicians who need a clear operational overview of how Q4272 functions within claims. Data not available in the input for payer-specific rates, associated taxonomies, and related ICD-10 diagnoses is noted where relevant.
Billing Code Overview
HCPCS Level II code Q4272 represents Esano a, per square centimeter (add-on, list separately in addition to primary procedure). This code is an add-on service that denotes a procedure or product billed in addition to a primary procedure and is intended to be reported on the same claim line or service line as the primary service.
Service type: Procedure/product billed per square centimeter as an add-on service.
Typical site of service: Settings where adjunct procedural products or localized treatments are applied and billed in addition to a primary procedure, such as outpatient procedure areas, ambulatory surgical centers, or facility-based procedural suites.
Data not available in the input for associated taxonomies, linked ICD-10 diagnoses, related procedure codes, and service line details.
Clinical & Coding Specifications
Clinical Context
A patient with a localized cutaneous lesion (for example, a chronic nonhealing ulcer or a dermatologic malignancy site) undergoes a procedure in which topical or implanted escharotic agent product measured and billed by surface area in square centimeters is applied as an adjunct to a primary procedure. The clinical workflow begins with evaluation in an outpatient dermatology or wound care clinic: history and targeted exam, photography and measurement of the lesion surface area, and selection of the appropriate escharotic product. The primary procedure (for example, debridement, excision, or lesion destruction) is performed first; Q4272 is reported as an add-on, per square centimeter, to reflect the additional escharotic product used to treat the wound or lesion surface. Documentation includes the primary procedure code, a precise measurement of the surface area treated (recorded in square centimeters), the clinical indication (wound, neoplasm, or hypergranulation), and the rationale for adjunctive escharotic therapy. Typical sites of service are outpatient hospital-based clinic, ambulatory surgery center, or dermatologist office. Common patients are adults with chronic ulcers, infected wounds requiring chemical debridement adjuncts, or patients undergoing topical chemical treatment of superficial skin malignancies where the escharotic is measured and billed by area.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier — standard reporting |